Additionally, using in vivo models, downregulation of CAV1 in breast-cancer stem cells also effectively impaired the tumorigenicity and chemoresistance [65], highlighting the importance of the CAV1-regulated β-catenin/ABCG2 signaling axis in chemoresistance of breast-cancer stem cells. The gene discussed is CAV1; the disease is breast cancer.